Results 1 to 10 of about 516 (139)
Challenges in schizoaffetive disorder therapeutic – a case report of a patient with hiperprolactinemia [PDF]
Introduction The only FDA approval therapeutic for schizoaffective disorder is paliperidone. Hiperprolactinemia is one of the most frequent side effects induced by first generation antipsychotics (FGA) or by second generation antipsychotic (SGA), such as
Rodrigues D +3 more
europepmc +4 more sources
[Narcolepsy secondary to a rare fatal disease]. [PDF]
Fontana-García N +5 more
europepmc +1 more source
Langerhans cell histiocytosis: Case report and literature review [PDF]
Medina MÁ +3 more
europepmc +1 more source
[Erdheim-Chester disease: a rare histiocytosis with outstanding response to cobimetinib.] [PDF]
Sosa GA +5 more
europepmc +1 more source
[Hip fractures in patients treated with antipsychotic drugs. Study of retrospective cohorts in Catalonia]. [PDF]
González Tejón S +5 more
europepmc +1 more source
The role of cannabinoids in neurodevelopmental disorders of children and adolescents. [PDF]
Dias-de Freitas F +5 more
europepmc +1 more source
Position Statement on Ischemic Heart Disease - Women-Centered Health Care - 2023. [PDF]
Oliveira GMM +51 more
europepmc +1 more source

